Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
France national soccer team trains ahead of face-off with Turkey
VIDEO SHOWS: PLAYERS IN FRENCH NATIONAL SOCCER TEAM ARRIVING AND TRAINING AHEAD OF UEFA NATIONS…
UK exclusion from EU 'Made in Europe' plan risks British auto trade, lobby says
Sept 22 (Reuters) - Britain's exclusion from the European Union's proposed "Made in Europe" provisions…
A history of Warner Bros — from old Hollywood to streaming era
Sept 21 (Reuters) - Paramount Skydance on Monday reached a settlement with California and 11…
